© Reuters Teva ADR Earnings, Revenue Miss in Q3
Investing.com – Teva ADR reported on Thursday third quarter that missed analysts’ forecasts and revenue that fell short of expectations.
Teva ADR announced earnings per share of $0.59 on revenue of $3.6B. Analysts polled by Investing.com anticipated EPS of $0.62 on revenue of $3.85B.
Teva ADR shares are down 39.61% from the beginning of the year, still down 22.75% from its 52 week high of $11.34 set on August 11.
Teva ADR shares lost 4.68% in pre-market trade following the report.
Teva ADR follows other major Healthcare sector earnings this month
Teva ADR’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Be the first to comment